RE:RE:RE:RE:There will be no increase in share price unless...Yes - you are right that it has doubled this year. So, assuming that they raise the dividend and the share price follows accordingly, perhaps I will utlimately take it off the candidate list for tax loss selling. At present, it is still down about 40% from purchase price. I did not purchase additional shares at the bottom, as I did not trust the management. In the case of Chemtrade, the price dropped biggly when they slashed their distribution, but I had enough confidence to buy more units during the March 2020 Wu Flu market collapse - so my ACB is much lower now and, at current prices, I am almost at break-even. Plus Chemtrade pays approx. 8% yield vs. 4% on this dog! Cheers!
flamingogold wrote: I believe the majority of tax loss selling for DR was done in 2019 when it fell from the heavens of $17+ to the $4's. So far though this year it has doubled and now is flat going back 2 years so not an incentive to sell for tax loss. But buyers from 3 years ago are a differrent story espeically for those that did not average down during covid. They may look to sell but I believe most of them have already exercised that option. Tax loss this year will be rampant in the pot sector.
CanSiamCyp wrote: Flamingo: Your point about getting paid to wait is 100% spot on! Dogs like CGX and VET that were forced to eliminate their dividend were cut as soon as I felt their market price had recovered a bit from the March lows. That is why DR was not cut, but is instead in the waiting list of potential tax loss selling candidates. Cheers!
flamingogold wrote: Understand the frustration, I have held through the storm and picked up some cheapies along the way. There is some light ahead as we recently broke long term resistance and today we are up again. IMO, the expectation is that a divy increase is on the horizon. At least we get paid something to wait which is not always the case for some of our portfolio dogs.
CanSiamCyp wrote: This dog will not increase it's share price unless they begin to increase the dividend payable. Who in their right mind would buy in now with such a low yield - given the dismal track record of management. FYI: I have owned this dog for several years, having endured the decimation of the dividend and the share price. It is now first on my list of liquidation candidates whenever offsetting capital losses are required. Of course, I still hold out hope that management will learn from previous mistakes AND increase the dividend to a more attractive level.